# US 8,278,118 B2 · Method for the fractionation and separation of particles by step-wise gradient density extraction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,118 B2
- Document ID: US8278118B2
- Status: Granted
- Kind: B2
- Application number: 12/380,907
- Filed: 2009-03-05
- Published: 2009-10-22
- Granted: 2012-10-02
- Earliest claimed: 2006-05-26
- Assignees: Prospect Biosystems, Inc.
- Inventors: Marcus Joseph Horn; Wenkui Lan
- Web page: https://patentgrep.com/patent/US8278118B2

## CPC

- B01D 21/262: {by using a centrifuge}
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- B01D 2221/10: Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues
- G01N 15/042: {by centrifuging and investigating centrifugates (centrifuges per se B04B)}
- Y10T 436/25375: Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A method for the separation of particles of different densities using a step-wise gradient density extraction method as described herein where a sample is suspended in a liquid volume of an extracting medium of specific density and the particles that have a density less than or equal to that of the extracting medium of specific density can be recovered from a horizonatally rotatable hollow disk or a removable receptacle within a horizontally rotatable hollow disk designed for such purposes while the particles that have a density greater than the extracting medium of specific density form a deposit which can be cycled through the extraction process in an iterative fashion by varying the density of the extracting medium allowing the recovery of discrete particles of differing densities from a test sample. Also disclosed herein is the use of the above method as part of a separate method or system to identify a ratio of biomarkers from different fractions of a sample homogenate or lysate which is useful in the evaluation of potential biomarkers, and for the intraoperative pathological diagnosis of positive margins of cancer and other diseases.

## Claims

### Claim 1

A method for the fractionation of cell lysates, tissue lysates, cell homogenates, or tissue homogenates contained in a sample into separate particles with different densities by centrifugal sedimentation in a centrifuge sedimentation chamber containing the sample suspended in a volume of an extracting medium of specific density such that said particles having a density less than or equal to said extracting medium will not sediment and said particles having a density greater than said extracting medium will move through the volume of the extracting medium, said method comprising the steps of:
(a) delivering said sample to be analyzed as a suspension in said volume of an extracting medium of specific density to said sedimentation chamber;
(b) spinning said centrifuge sedimentation chamber at the axis of rotation for a period of time between about 1 minute to about 2 hours at a centrifugal force between about 500 g to about 200,000 g;
(c) allowing said particles having a density greater than said extracting medium of specific density to form a deposit on the inside wall of said sedimentation chamber;
(d) removing the extracting medium from the sedimentation chamber to recover said particles having a density less than or equal to said extracting medium of specific density;
(e) delivering to said sedimentation chamber a liquid volume of an extracting medium of a specific density that is different from that used in the extracting medium of step (c);
(f) resuspending in said sedimentation chamber the deposited particles from step (c) by agitation with the extracting medium of step (e);
(g) repeating steps (b)-(f) to isolate at least two fractions of different densities from said sample;
(h) repeating steps (a)-(g) with a second sample to isolate at least two fractions of said second sample where the second sample fractions are the same densities as the fractions in step (g);
(i) quantitatively analyzing one or more biomarkers within each of said fractions from steps (g) and (h) from each sample to obtain a value;
(j) pairing the value for each fraction within a sample to the value for every other fraction within the sample to determine ratios between all pairs of fractions from step (g) and all pairs of fractions from step (h); and
(k) comparing said ratios obtained from step (j) for the group of fractions from step (g) to said ratios obtained from step (j) for the group of fractions from step (h) to determine whether there is a statistical difference between said ratios.

### Claim 2 (depends on 1)

The method of claim 1, where said time in step (b) is between about 1 to about 30 minutes.

### Claim 3 (depends on 2)

The method of claim 2, where said time in step (b) is between about 1 to about 3 minutes.

### Claim 4 (depends on 1)

The method of claim 1, where said centrifugal force in step (b) is between about 500 g to about 150,000 g.

### Claim 5 (depends on 4)

The method of claim 4, where said centrifugal force in step (b) is between about 90,000 g to 110,000 g.

### Claim 6 (depends on 1)

The method of claim 1, where said particles of step (d) are recovered by aspiration of the volume of the extracting medium in said centrifuge sedimentation chamber.

### Claim 7 (depends on 1)

The method of claim 1, where said density of said extracting medium in step (e) is increased in equal increments at the completion of each repetition of step (d).

### Claim 8 (depends on 7)

The method of claim 7, where said density of said extracting medium in step (e) is increased by about 0.0001 g/ml to about 0.2 g/ml at the completion of said repetition of step (d).

### Claim 9 (depends on 1)

The method of claim 1, where said density of said extracting medium in step (e) is increased in unequal increments at the completion of each repetition of step (d).

### Claim 10 (depends on 9)

The method of claim 9, where said density of said extracting medium in step (e) is increased by about 0.0001 g/ml to about 0.2 g/ml at the completion of said repetition of step (d).

### Claim 11 (depends on 1)

The method of claim 1, where said volume of the extracting medium of specific density consists essentially of an aqueous mixture of a sugar and distilled, deionized water which contains a salt buffer.

### Claim 12 (depends on 11)

The method of claim 11, where said sugar is selected from the group including sucrose, mannose, glucose and fructose.

### Claim 13 (depends on 11)

The method of claim 11, where said aqueous mixture consists of about 4.0 to about 75% by weight per volume of sucrose or mannose.

### Claim 14 (depends on 1)

The method of claim 1, where said liquid volume of extracting medium of specific density consists essentially of an aqueous mixture of a salt and distilled, deionized water.

### Claim 15 (depends on 14)

The method of claim 14, where said salt is selected from the group consisting essentially of inorganic or organic salts of cesium, potassium and sodium.

### Claim 16 (depends on 15)

The method of claim 15, where said salt is selected from the group consisting of cesium chloride, sodium bromide, and potassium bromide.

### Claim 17 (depends on 1)

The method of claim 1, where said volume of extracting medium is from about 0.001 to about 50 milliliters.

### Claim 18 (depends on 17)

The method of claim 17, where said volume of extracting medium is from about 0.050 to about 0.500 milliliters.

### Claim 19 (depends on 1)

The method of claim 1, where said specific density in step (a) is from about 1.001 g/ml to about 2.0 g/ml.

### Claim 20 (depends on 1)

The method of claim 1, where said sample is selected from the group consisting essentially of mammalian, plant, bacterial, yeast and fungal tissues and/or cells.

### Claim 21 (depends on 1)

The method of claim 1, where said particle is a cell organelle.

### Claim 22 (depends on 21)

The method of claim 21, where said cell organelle is the Golgi apparatus.

### Claim 23 (depends on 21)

The method of claim 21, where said cell organelle is the mitochondria.

### Claim 24 (depends on 1)

The method of claim 1, where said particle is the plasma membrane.

### Claim 25 (depends on 1)

The method of claim 1, where said particle is a lipoprotein.

### Claim 26 (depends on 25)

The method of claim 25, where said lipoprotein is high density lipoprotein (HDL).

### Claim 27 (depends on 25)

The method of claim 25, where said lipoprotein is low density lipoprotein (LDL).

### Claim 28 (depends on 25)

The method of claim 25, where said lipoprotein is very low density lipoprotein (VLDL).

### Claim 29 (depends on 1)

The method of claim 1, where said deposit is not observable via total protein analysis.

### Claim 30 (depends on 1)

The method of claim 1, where said centrifuge sedimentation chamber is defined as the physical space wherein the particles are deposited or remain suspended following application of a force.

### Claim 31 (depends on 30)

The method of claim 30, where said physical space is within a horizontally rotatable hollow disk in a centrifuge.

### Claim 32 (depends on 30)

The method of claim 30, where said physical space is within a removable receptacle that is inserted into a horizontally rotatable hollow disk in a centrifuge.

### Claim 33 (depends on 1)

The method of claim 1, where said sample is from a rat, dog, mouse, or man.

### Claim 34 (depends on 1)

The method of claim 1, where said biomarker in step (i) is p-synapsin I.

### Claim 35 (depends on 1)

The method of claim 1, where said biomarker in step (i) is GRP 75.

### Claim 36 (depends on 1)

The method of claim 1, where said biomarker in step (i) is GRP 78.

### Claim 37 (depends on 1)

The method of claim 1, where said sample in steps (g) and (h) are derived from rat brain.

### Claim 38 (depends on 1)

The method of claim 1, where said sample in steps (g) and (h) are derived from rat heart.

### Claim 39 (depends on 1)

The method of claim 1, where said sample in steps (g) and (h) are derived from human prostate tissue.

### Claim 40 (depends on 1)

The method of claim 1, where said quantitative analysis in step (i) is selected from the group consisting of, individually or in combination, Western Blot analysis, mass spectrometry, and ELISA.

### Claim 41 (depends on 1)

The method of claim 1, further comprising the step of repeating steps (b)-(f) cyclically until the deposit of step (c) is not observable or a specific density of an extracting medium is reached.

### Claim 42

A method for the fractionation of cell lysates, tissue lysates, cell homogenates, or tissue homogenates contained in a sample into separate particles with different densities by centrifugal sedimentation in a centrifuge sedimentation chamber containing the sample suspended in a volume of an extracting medium of specific density such that said particles having a density less than or equal to said extracting medium will not sediment and said particles having a density greater than said extracting medium will move through the volume of the extracting medium, said method comprising the steps of:
(a) delivering said sample to be analyzed as a suspension in said volume of an extracting medium of specific density to said sedimentation chamber;
(b) spinning said centrifuge sedimentation chamber at the axis of rotation for a period of time between about 1 minute to about 2 hours at a centrifugal force between about 500 g to about 200,000 g;
(c) allowing said particles having a density greater than said extracting medium of specific density to form a deposit on the inside wall of said sedimentation chamber;
(d) removing the extracting medium from the sedimentation chamber to recover said particles having a density less than or equal to said extracting medium of specific density;
(e) delivering to said sedimentation chamber a liquid volume of an extracting medium of a specific density that is different from that used in the extracting medium of step (c);
(f) resuspending in said sedimentation chamber the deposited particles from step (c) by agitation with the extraction medium of step (e);
(g) repeating steps (b)-(f) to isolate at least two fractions of different densities from said sample;
(h) repeating steps (a)-(g) with a second sample to isolate at least two fractions of said second sample where the second sample fractions isolated are the same densities as the fractions in step (g);
(i) quantitatively analyzing one or more biomarkers within each of said fractions from steps (g) and (h) from each sample to obtain a value;
(j) pairing the value for each fraction within a sample to the value for every other fraction within the sample to determine ratios between all pairs of fractions from step (g) and all pairs of fractions from step (h);
(k) repeating steps (a)-(g) with a test sample to isolate at least two fractions of said test sample where the test sample fractions isolated are the same densities as the fractions in step (g);
(l) quantitatively analyzing one or more biomarkers within each of said fractions from step (k) to obtain a value;
(m) pairing the value for each fraction within the test sample to the value for every other fraction within the test sample to determine ratios between all pairs of fractions from step (k); and
(n) comparing said ratios obtained from step (j) for the group of fractions from step (g), the ratios obtained from step (j) for the group of fractions from step (h), and the ratios obtained from step (m) for the group of fractions from step (k) to determine whether there is a statistical difference among said ratios.

### Claim 43 (depends on 42)

The method of claim 42, where said sample is from a rat, dog, mouse or man.

### Claim 44 (depends on 42)

The method of claim 42, where said biomarker in step (i) is p-synapsin I.

### Claim 45 (depends on 42)

The method of claim 42, where said biomarker in step (i) is GRP 75.

### Claim 46 (depends on 42)

The method of claim 42, where said biomarker in step (i) is GRP 78.

### Claim 47 (depends on 42)

The method of claim 42, where said sample in steps (g) and (h) are derived from rat brain.

### Claim 48 (depends on 42)

The method of claim 42, where said sample in steps (g) and (h) are derived from rat heart.

### Claim 49 (depends on 42)

The method of claim 42, where said sample in steps (g) and (h) are derived from human prostate tissue.

### Claim 50 (depends on 42)

The method of claim 42, where said quantitative analysis in step (i) is selected from the group consisting of, individually or in combination, Western Blot analysis, mass spectrometry, and ELISA.

### Claim 51 (depends on 42)

The method of claim 42, further comprising the step of repeating steps (b)-(f) cyclically until the deposit of step (c) is not observable or a specific density of an extracting medium is reached.
